|
neocarzinostatin chromophore |
|
CHEBI:29655 |
|
A naphthoate ester obtained by formal condensation of the carboxy group of 2-hydroxy-7-methoxy-5-methyl-1-naphthoic acid with the 5-hydroxy group of (1aS,5R,6R,6aE,9aR)-5-hydroxy-1a-[(4R)-2-oxo-1,3-dioxolan-4-yl]-2,3,8,9-tetradehydro-1a,5,6,9a-tetrahydrocyclopenta[5,6]cyclonona[1,2-b]oxiren-6-yl 2,6-dideoxy-2-(methylamino)-α-D-galactopyranoside. The chromophoric part of neocarzinostatin, it is tightly and non-covelently bound to a 113-membered apoprotein, which serves to protect it and release it to the target DNA. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
CHEBI:41563
|
|
|
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C35H33NO12/c1-16-12-19(42-4)14-22-20(16)8-9-23(37)27(22)32(40)45-24-13-18-10-11-35(26-15-43-34(41)46-26)25(48-35)7-5-6-21(18)31(24)47-33-28(36-3)30(39)29(38)17(2)44-33/h6,8-9,12-14,17,24-26,28-31,33,36-39H,15H2,1-4H3/b21-6+/t17-,24-,25-,26-,28-,29+,30-,31-,33-,35+/m1/s1 |
QZGIWPZCWHMVQL-UIYAJPBUSA-N |
CN[C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](OC(=O)c2c(O)ccc3c(C)cc(OC)cc23)C=C2C#C[C@@]3(O[C@@H]3C#C/C=C1\2)[C@H]1COC(=O)O1 |
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1aS,5R,6R,6aE,9aR)-6-{[2,6-dideoxy-2-(methylamino)-α-D-galactopyranosyl]oxy}-1a-[(4R)-2-oxo-1,3-dioxolan-4-yl]-2,3,8,9-tetradehydro-1a,5,6,9a-tetrahydrocyclopenta[5,6]cyclonona[1,2-b]oxiren-5-yl 2-hydroxy-7-methoxy-5-methyl-1-naphthoate
|
Ncs-chrom
|
ChemIDplus
|
Neocarzinostatin chromophore
|
KEGG COMPOUND
|
4224827
|
Reaxys Registry Number
|
Reaxys
|
81604-85-5
|
CAS Registry Number
|
KEGG COMPOUND
|
81604-85-5
|
CAS Registry Number
|
ChemIDplus
|
11735421
|
PubMed citation
|
Europe PMC
|
11916399
|
PubMed citation
|
Europe PMC
|
11955061
|
PubMed citation
|
Europe PMC
|
16546380
|
PubMed citation
|
Europe PMC
|
20336247
|
PubMed citation
|
Europe PMC
|
20735485
|
PubMed citation
|
Europe PMC
|
2524463
|
PubMed citation
|
Europe PMC
|
2976601
|
PubMed citation
|
Europe PMC
|
6220205
|
PubMed citation
|
Europe PMC
|
6223633
|
PubMed citation
|
Europe PMC
|
7582949
|
PubMed citation
|
Europe PMC
|
7582957
|
PubMed citation
|
Europe PMC
|
8362243
|
PubMed citation
|
Europe PMC
|
8466903
|
PubMed citation
|
Europe PMC
|
|